27
Participants
Start Date
July 31, 2004
Primary Completion Date
May 31, 2006
Study Completion Date
May 31, 2010
Cisplatin
Intravenously once every three weeks for a total of 12 weeks
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Massachusetts General Hospital, Boston
Collaborators (1)
Beth Israel Deaconess Medical Center
OTHER
Massachusetts General Hospital
OTHER
Brigham and Women's Hospital
OTHER
Breast Cancer Research Foundation
OTHER
Dana-Farber Cancer Institute
OTHER